Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
about
A multicentre randomized controlled trial of an empowerment-inspired intervention for adolescents starting continuous subcutaneous insulin infusion--a study protocol.Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps.The effectiveness and durability of an early insulin pump therapy in children and adolescents with type 1 diabetes mellitusStudy protocol for a randomised controlled trial of insulin delivery by continuous subcutaneous infusion compared to multiple daily injections.A Comparison of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Insulin Injection in Children with Type I Diabetes in Kuwait: Glycemic Control, Insulin Requirement, and BMI.Insulin doses before and one year after pump start: children have a reversed dawn phenomenon.Past, present, and future of insulin pump therapy: better shot at diabetes control.Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetesImproved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis.Changes in glycemic control and quality of life in pediatric type 1 diabetics with continuous subcutaneous insulin infusion of insulin aspart following multiple daily injection therapy.Insulin delivery by injection in children and adolescents with diabetes.New technologies for diabetes: a review of the present and the future.20 Years of insulin lispro in pediatric type 1 diabetes: a review of available evidence.Optimum bolus wizard settings in insulin pumps in children with Type 1 diabetes.Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes.Metabolic control of TYPE 1 Diabetes in children treated with insulin pump therapy.The influence of age, gender, insulin dose, BMI, and blood pressure on metabolic control in young patients with type 1 diabetes.Insulin pump therapy in children and adolescents: changes in dietary habits, composition and quality of life.Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study.[Insulin pump therapy in patients with type 1 diabetes].Insulin pump therapy: impact on the lives of children/young people with diabetes mellitus and their parents.A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes.Poor adherence to integral daily tasks limits the efficacy of CSII in youth
P2860
Q31146468-F6C8ACA5-38D6-4994-AADB-7BA5939DA103Q33879565-53F4384A-0E01-41D8-A075-DCBD2C1DD975Q34360873-043DA3E1-61B6-42C9-A559-1EAE14E69FE2Q35538888-377E01A4-6001-4665-AA19-D46C3DE3DB15Q36076863-B0BCE428-38A6-4216-82F4-B5AED920113BQ36229004-00ECA45F-A84C-4E19-AE52-B80774406777Q36924597-7BDD561B-1FAC-4045-9496-A5F1D4CC41FCQ37280760-CE761375-5E26-4400-99F3-D6DB0FB4A8BFQ37460079-EC959E80-CDFB-4D6E-9173-DE84D765858AQ37732876-EEE299F7-688C-4BD2-A629-53BF18F6F836Q37863741-D7D5F6AF-9CC3-4202-B87B-F2D179C2CCEBQ38055490-7015FDD8-EB0D-4F06-A1EC-EB2246990FD7Q38889745-4D096005-B5A1-4076-BED8-F29B5212A02BQ40101385-0E5EB405-B195-4E9F-A9F2-83698007FFFDQ40693872-997AB268-6AFC-4B0D-A357-62A8F172E184Q42375658-36559420-1E6D-4A43-8410-5CAB538D968FQ43927536-B42EDF5D-D327-4B28-844D-A0172C553BEEQ44686244-23E2A9E0-CBB3-4CD8-8549-C5614C7A8E09Q45302237-93B60C16-1A7C-4761-9D98-B1195BFDC14CQ46625413-BBF62A71-73EB-49E7-89C8-8B9EA73FEE18Q48068782-D0001768-E66F-40B8-98B6-83115409F33FQ50987466-49246A29-E81F-4FAD-B70B-ABE2F4EFC5E9Q57776950-A694D3F0-6959-4CA0-BB64-8BC9AD7044C3
P2860
Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Long-term benefits of continuo ...... diabetes: a 4-year follow-up.
@en
Long-term benefits of continuo ...... diabetes: a 4-year follow-up.
@nl
type
label
Long-term benefits of continuo ...... diabetes: a 4-year follow-up.
@en
Long-term benefits of continuo ...... diabetes: a 4-year follow-up.
@nl
prefLabel
Long-term benefits of continuo ...... diabetes: a 4-year follow-up.
@en
Long-term benefits of continuo ...... diabetes: a 4-year follow-up.
@nl
P2860
P1433
P1476
Long-term benefits of continuo ...... diabetes: a 4-year follow-up.
@en
P2093
P2860
P304
P356
10.1111/J.1464-5491.2006.01935.X
P577
2006-08-01T00:00:00Z